United Therapeutics Corporation is a company in the U.S. stock market and it is a holding in 94 U.S.-traded ETFs. UTHR has around 6.2M shares in the U.S. ETF market. The largest ETF holder of UTHR is the iShares Core S&P Mid-Cap ETF (IJH), with approximately 1.21M shares. Investors may also find of interest that the ETF with the largest allocation to UTHR stock is ALPS Medical Breakthroughs ETF (SBIO), with a portfolio weight of 4.61%. On average, U.S. ETFs allocate 0.38% of UTHR to their portfolios.
Additionally, UTHR is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with UTHR as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 21.51%.